Web firms lobby FDA to ease regulations on drug ads
Google, Yahoo! and a fleet of Web firms, ad agencies and drug companies all joined Thursday in urging the Food and Drug Administration to adjust existing advertising regulations, which currently make it difficult to engage in online pharmaceutical marketing. Online efforts accounted for just 3% of the $4.3 billion that drug companies spent on patient-targeted marketing last year; the problem, the companies say, is the requirements for fine print, which can't fit in online search or banner ads.
Google
| 11/12
This story published in 4A's SmartBrief on 11/13/2009
|
4A's SmartBrief
Designed specifically for advertising, media, and marcom executives, 4A's SmartBrief is a FREE, daily e-mail newsletter. By providing the latest need-to-know industry news and information, 4A's SmartBrief saves you time and keeps you smart. Learn more |
|